SCHEMBL21990365

SCHEMBL21990365

CC(C)(C)c1ccc(C(=O)C(Br)c2ccc(F)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
XBP1 P17861 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
GSK3B P49841 1/20 0.44
GAA P10253 1/20 0.43
RAPGEF3 O95398 4/20 0.42
RAPGEF4 Q8WZA2 3/20 0.42
NR1H4 Q96RI1 2/20 0.42
HDAC1 Q13547 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2534850 0.87 CES2 (0.48) ALDH1A1SMN1; SMN2NPC1HTTRAB9A
SCHEMBL3098687 0.82 MAPT (0.59) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL6619666 0.81 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10MAPTSMN1; SMN2
SCHEMBL7144741 0.81 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10MAPTMEN1
Bromide SCHEMBL6280874 0.80 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10MAPTMEN1
Bromide SCHEMBL6545831 0.80 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10MAPTSMN1; SMN2
SCHEMBL10392108 0.79 MDM2 (0.47) ALDH1A1HTTCES2CES1TP53
SCHEMBL682581 0.78 CES2 (0.53) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1121616 0.78 LMNA (0.49) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL7508723 0.78 PLK1 (0.41) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174253-B2 Compound and pharmaceutical composition containing the same ALPHALA CO., LTD. (TW) 2021-11-16 US disclosed
US-20200172531-A1 Novel compound and pharmaceutical composition containing the same ALPHALA CO., LTD. (TW) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172531-A1 Novel compound and pharmaceutical composition containing the same H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, F12, ZYX ALDH1A1 2703/4885TSHR 2518/4885HSD17B10 1928/4885
US-11174253-B2 Compound and pharmaceutical composition containing the same F12, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ZYX ALDH1A1 1878/4885TSHR 2686/4885HSD17B10 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.